|
COPYRIGHT 2004 Thomson Financial Inc.
The 340B program is supposed to guarantee that community health centers, public hospitals, and other federal grantees, such as family-planning clinics and black-lung clinics, that deliver care to disadvantaged populations can get prescription drugs for patients at low cost. But, much of the time, pharmaceutical manufacturers overcharge these safety-net institutions by substantial amounts, according to a new report by the...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
